PubRank

P Nos

Author PubWeight™ 15.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adverse effects of azathioprine in the treatment of inflammatory bowel disease. Rev Esp Enferm Dig 2001 1.44
2 [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. Rev Esp Enferm Dig 1995 1.38
3 Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 1998 1.14
4 Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 2013 1.06
5 Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005 1.00
6 Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability. Aliment Pharmacol Ther 2009 0.95
7 Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther 2005 0.94
8 Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis 2001 0.90
9 Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 2013 0.89
10 [Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease]. Gastroenterol Hepatol 2006 0.88
11 Healthcare seeking for constipation: a population-based survey in the Mediterranean area of Spain. Aliment Pharmacol Ther 2006 0.85
12 [Esophageal pseudoachalasia related to a neoplasm]. Rev Esp Enferm Dig 1993 0.83
13 Long-term durability of response to adalimumab in Crohn's disease. Inflamm Bowel Dis 2011 0.81
14 Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease. Gut 2006 0.77
15 HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease. Rev Esp Enferm Dig 2003 0.76
16 Evolutive pattern in Crohn's disease: a simplified index using clinical parameters predicts obstructive behaviour. Eur J Gastroenterol Hepatol 2001 0.75
17 [Acute flutamide-induced hepatitis]. Gastroenterol Hepatol 1999 0.75
18 [Cyclosporine in ulcerative colitis flares]. Gastroenterol Hepatol 2005 0.75
19 [Severe lower digestive hemorrhage in Crohn's disease]. Gastroenterol Hepatol 1999 0.75
20 [Sigmoid stenosis as a complication of severe acute pancreatitis]. Rev Esp Enferm Dig 1995 0.75
21 [Hepatitis associated with taking diclofenac]. Rev Esp Enferm Dig 1992 0.75
22 [Lansoprazol]. Gastroenterol Hepatol 1995 0.75
23 [Sciatica secondary to a presacral abscess as the first manifestation of Crohn's disease]. Gastroenterol Hepatol 2002 0.75
24 [Comparison of the efficacy of cleaning and disinfection of videoscopes: mechanized versus manual]. Gastroenterol Hepatol 2000 0.75
25 [Adult celiac disease and hepatopathy]. Rev Esp Enferm Dig 1991 0.75
26 [Focal nodular hyperplasia of the liver: benign lesion with often surgical treatment. Magnetic resonance and laparoscopic findings]. Gastroenterol Hepatol 1995 0.75
27 [Budesonide and inflammatory bowel disease]. Gastroenterol Hepatol 1999 0.75
28 [Cyclosporin in an oral microemulsion as the initial treatment of corticoid-refractory ulcerative colitis]. Gastroenterol Hepatol 2000 0.75
29 [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease]. Gastroenterol Hepatol 1998 0.75
30 [Calcification of the portal vein associated with hepatocarcinoma]. Rev Esp Enferm Dig 1991 0.75
31 [Endoscopic prosthesis insertion in the palliative treatment of malignant esophageal stenosis. (Endoscopic esophageal prosthesis)]. Rev Esp Enferm Dig 1993 0.75